965.5 928.3 1,465.3 37.2 4.0 (499.8) (34.1) Profit for the period 61.8 72.1 123.4 (10.3) (14.3) (61.6) (49.9) In Q3–2018, the Company’s total revenue was similar to Q2–2018 with a slight increase

Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549

: Million Baht Projects Consolidated Revenue Project Revenue Increase (Decrease) % Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) 30th-Sep-19 30th-Sep-18 30th-Sep

amount to a decrease rate of 13.14 percent in 2019. The Company’s gross profit margins in 2018 – 2019 were equal to 17.14 percent and 19.89 percent, respectively. The increase in the gross profit market

period ended June 30, 2020, resulted in increase in total comprehensive income of Baht 59.64 million or 283.00% from the corresponding period of the previous year as the following details below: 1. Revenue

of following key factors: 1. Revenue from sales of electricity were THB 173 million in the third quarter of 2020, which increased by THB 81 million or 89% from the same period last year. The increase

17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2

more than its target, which reflected in 2019 gross margin increase by 250 bps YoY to 34.9%. Q4’19 Gross margin was slightly improved 50 bps YoY and recorded at 35.0%, despite the impact of new sugar tax

Company, wishes to raise funds through an increase of its registered capital and offer such newly issued ordinary shares to the public by an initial public offering (the “IPO”) and subsequently list its

early 2018. - OSP energy drink market share was at 54%. Q4’18 M150 market share was at 37.9% increase by 90bps QOQ. C-Vitt took over leadership position in functional drink market, with Q4’18 market share